FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...